IUS Publications

Found 25 results
Filters: Author is Altijana Hromic-Jahjefendic  [Clear All Filters]
2024
A. Hromic-Jahjefendic, Chavda, V. P., and Nalla, L. Vineela, Socio-Economic and Environmental Impact of SARS-CoV-2 Variants, in SARS-CoV-2 Variants and Global Population Vulnerability, CRC Press, 2024, pp. 479-507.
2023
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Špirtović-Halilović, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells, Croatica Chemica Acta, vol. 96, 2023.
A. Hromic-Jahjefendic, Barh, D., Uversky, V., Aljabali, A. A., Tambuwala, M. M., Alzahrani, K. J., Alzahrani, F. M., Alshammeri, S., and Lundstrom, K., Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?, MDPI Vaccines, 2023.
K. Lundstrom, Hromic-Jahjefendic, A., and Bilajac, E., COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity, Cellular Signaling, 2023.
K. Lundstrom, Hromic-Jahjefendic, A., and Bilajac, E., COVID-19 signalome: Potential therapeutic interventions, Cellular Signaling, vol. 103, 2023.
A. Hromic-Jahjefendic, Sezer, A., Aljabali, A. A. A., Serrano-Aroca, Ã., Tambuwala, M. M., Uversky, V. N., Redwan, E. M., Barh, D., and Lundstrom, K., COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence, MDPI Biomedicines, vol. 11, no. 5, 2023.
E. Pašalić, Tambuwala, M. M., and Hromic-Jahjefendic, A., ENDOMETRIOSIS: CLASSIFICATION, PATHOPHISIOLOGY, AND TREATMENT OPTIONS, Pathology - Research and Practice, 2023.
A. Cosic, Islam, N., and Hromic-Jahjefendic, A., Molecular analysis of 16s-rRNA and associated gene segments for identification of probiotic phenotypes, Periodicals of Engineering and Natural Sciences, vol. 11, 2023.
A. A. Aljabali, Obeid, M. A., Obeid, M. A., Serrano-Aroca, Ã., Mishra, V., Mishra, Y., El-Tanani, M., Hromic-Jahjefendic, A., Kapoor, D. N., Goyal, R., Naikoo, G. A., and Tambuwala, M. M., Nanomaterials and Their Impact on the Immune System, MDPI International Journal of Molecular Sciences, 2023.
2022
Y. Mishra, Amin, H. Ibrahim M., Mishra, V., Vyas, M., Prabhakar, P. Kumar, Gupta, M., Kanday, R., Sudhakar, K., Saini, S., Hromic-Jahjefendic, A., Aljabali, A. A. A., El-Tanani, M., Serrano-Aroca, Ã., Bakshi, H., and Tambuwala, M. M., Application of nanotechnology to herbal antioxidants as improved phytomedicine: An expanding horizon, Biomedicine & Pharmacotherapy, vol. 153, 2022.
A. Hromic-Jahjefendic, Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review, Viruses, vol. 14, no. 5, 2022.
N. Bharat Charbe, Tambuwala, M., Palakurthi, S. Srivatsa, Warokar, A., Hromic-Jahjefendic, A., Bakshi, H., Zacconi, F., Mishra, V., Khadse, S., Aljabali, A. A., El-Tanani, M., Serrano-Aroca, Ã., and Palakurthi, S., Biomedical applications of three-dimensional bioprinted craniofacial tissue engineering, Bioengineering and Translational Medicine, 2022.
M. Adilovic, Correlation of model quality between predicted proteins and their templates, Periodicals of Engineering and Natural Sciences, vol. 10, 1 vol., pp. 481-490, 2022.
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M. M., and Suljagic, M., Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines, MDPI Metabolites, vol. 13, 2022.
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M., and Suljagic, M., Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines, MDPI Metabolites, 2022.
A. Kumasin, Testing temperature and pH stability of the catalase enzyme in the presence of inhibitors, Periodicals of Engineering and Natural Sciences, vol. 10, 2 vol., pp. 18-29, 2022.
E. Bilajac, Mahmutovic, L., Lundstrom, K., Glamočloja, U., Šutković, J., Sezer, A., and Hromic-Jahjefendic, A., Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis, MDPI Viruses, 2022.